Literature DB >> 16517202

Expression profiling of host pathogen interactions: how Mycobacterium tuberculosis and the macrophage adapt to one another.

Dirk Schnappinger1, Gary K Schoolnik, Sabine Ehrt.   

Abstract

It has recently become feasible to quantify all mRNAs encoded by the genomes of bacterial pathogens and their eukaryotic host cells and to apply this approach to study the interaction of Mycobacterium tuberculosis with its primary host cell, the macrophage. These studies helped to identify regulatory circuits which mediate adaptation of the M. tuberculosis transcriptome to intraphagosomal environments and stimulated hypotheses for the function of these circuits in human tuberculosis. The macrophage transcriptome reacts to infections with the induction of a pathogen-unspecific expression program as well as the induction of pathogen-specific expression signatures, both of which contribute to the immunologic activation of the infected cell. M. tuberculosis induced changes in the macrophage transcriptome are mediated by Toll-like receptor dependent and Toll-like receptor independent signal transduction pathways. This response is shaped by macrophage produced reactive nitrogen and oxygen molecules and affected by viability and virulence of the pathogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517202     DOI: 10.1016/j.micinf.2005.10.027

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  22 in total

1.  Random inducible controlled expression (RICE) for identification of mycobacterial virulence genes.

Authors:  Harish K Janagama; Hany A Hassounah; Suat L G Cirillo; Jeffrey D Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2011-11-13       Impact factor: 3.131

Review 2.  Expression profiling in granulomatous lung disease.

Authors:  Edward S Chen; David R Moller
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  A systems chemical biology study of malate synthase and isocitrate lyase inhibition in Mycobacterium tuberculosis during active and NRP growth.

Authors:  Elebeoba E May; Andrei Leitão; Alexander Tropsha; Tudor I Oprea
Journal:  Comput Biol Chem       Date:  2013-09-04       Impact factor: 2.877

4.  [Elimination of Gibbs artifact based on local subpixel shift and interlaced local variation].

Authors:  Zhengce Wang; Kaixuan Zhao; Zhongbiao Xu; Yanqiu Feng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

Review 5.  Mycobacterium tuberculosis and the intimate discourse of a chronic infection.

Authors:  David G Russell
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

Review 6.  Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Authors:  Satria A Prabowo; Matthias I Gröschel; Ed D L Schmidt; Alena Skrahina; Traian Mihaescu; Serap Hastürk; Rotislav Mitrofanov; Edita Pimkina; Ildikó Visontai; Bouke de Jong; John L Stanford; Père-Joan Cardona; Stefan H E Kaufmann; Tjip S van der Werf
Journal:  Med Microbiol Immunol       Date:  2012-11-10       Impact factor: 3.402

7.  Sample preparation of Mycobacterium tuberculosis extracts for nuclear magnetic resonance metabolomic studies.

Authors:  Denise K Zinniel; Robert J Fenton; Steven Halouska; Robert Powers; Raul G Barletta
Journal:  J Vis Exp       Date:  2012-09-03       Impact factor: 1.355

Review 8.  Infectious (Non)tolerance--frustrated commensalism gone awry?

Authors:  Jesse C Nussbaum; Richard M Locksley
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-05-01       Impact factor: 10.005

9.  The adaptor molecule CARD9 is essential for tuberculosis control.

Authors:  Anca Dorhoi; Christiane Desel; Vladimir Yeremeev; Lydia Pradl; Volker Brinkmann; Hans-Joachim Mollenkopf; Karin Hanke; Olaf Gross; Jürgen Ruland; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2010-03-29       Impact factor: 14.307

Review 10.  Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?

Authors:  William R Berrington; Thomas R Hawn
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.